Cartesian Therapeutics, a biotech seeking to develop mRNA cell therapies for autoimmune diseases, was trading nearly 20% lower early in Tuesday’s trading. 3 July 2024
Reform of the procurement policies applied to generic medicines is needed to ensure greater security of supply for patients and health systems, according to Med 19 February 2024